...
首页> 外文期刊>Biochimica et biophysica acta: BBA: International journal of biochemistry, biophysics and molecular biololgy. Proteins and Proteomics >Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2
【24h】

Too much of a good thing: The role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2

机译:太好了:蛋白激酶CK2在肿瘤发生中的作用以及对CK2的治疗性抑制的前景

获取原文
获取原文并翻译 | 示例

摘要

CK2 is a highly conserved protein serine/threonine kinase that is ubiquitously distributed in eukaryotes, constitutively active and has been implicated in multiple cellular functions, as well as in tumorigenesis and transformation. Elevated CK2 activity has been associated with the malignant transfort-nation of several tissues and is associated with aggressive tumor behaviour. While the precise roles of CK2 in tumorigenesis remain incompletely understood, mounting evidence suggests a role for CK2 in the protection of cells from apoptosis via the regulation of tumor suppressor and oncogene activity. Consequently, CK2 has emerged as a potential therapeutic target, and strategies to inhibit CK2 have been ongoing in pre-clinical trials. This review will focus on published evidence highlighting the molecular mechanisms by which CK2 functions in the promotion of tumorigenesis, as well as review current strategies being used to inhibit CK2. (C) 2007 Elsevier B.V. All rights reserved.
机译:CK2是高度保守的丝氨酸/苏氨酸激酶,广泛分布在真核生物中,具有组成性活性,并已涉及多种细胞功能以及肿瘤发生和转化。 CK2活性升高与几种组织的恶性转化有关,并与侵袭性肿瘤行为有关。尽管CK2在肿瘤发生中的确切作用尚不完全清楚,但越来越多的证据表明CK2在通过调节肿瘤抑制因子和癌基因活性来保护细胞免于凋亡中发挥作用。因此,CK2已经成为潜在的治疗靶标,并且在临床前试验中一直在研究抑制CK2的策略。这篇综述将集中在已发表的证据上,这些证据突出了CK2促进肿瘤发生的分子机制,并综述了目前用于抑制CK2的策略。 (C)2007 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号